Pre-clincial, pre-revenue is why the continued downtrend. Anything that changes those 2 things in the slightest will launch this back up like a rubberband.

Also, The Investor's Presentation gets updated fairly regularly.

April 2017 link: http://www.owcpharma.com/wp-content/uploads/2...l-2017.pdf

http://www.owcpharma.com/investors/